"Sf9 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell line derived from SF21 CELLS which are a cell line isolated from primary explants of SPODOPTERA FRUGIPERDA pupal tissue.
| Descriptor ID |
D061987
|
| MeSH Number(s) |
A11.251.210.891
|
| Concept/Terms |
Sf9 Cells- Sf9 Cells
- Cell, Sf9
- Cells, Sf9
- Sf9 Cell
- Spodoptera frugiperda 9 Cells
Sf21 Cells- Sf21 Cells
- Cell, Sf21
- Cells, Sf21
- Sf21 Cell
- Spodoptera frugiperda 21 Cells
|
Below are MeSH descriptors whose meaning is more general than "Sf9 Cells".
Below are MeSH descriptors whose meaning is more specific than "Sf9 Cells".
This graph shows the total number of publications written about "Sf9 Cells" by people in this website by year, and whether "Sf9 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 7 | 7 |
| 2018 | 0 | 8 | 8 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 7 | 7 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Sf9 Cells" by people in Profiles.
-
Rapid and cost-effective process based on insect larvae for scale-up production of SARS-COV-2 spike protein for serological COVID-19 testing. Biotechnol Bioeng. 2021 10; 118(10):4129-4137.
-
Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice. Eur J Immunol. 2021 09; 51(9):2296-2305.
-
Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates. Sci Adv. 2021 05; 7(22).
-
RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. Nat Immunol. 2021 07; 22(7):820-828.
-
Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19. Cell Rep. 2021 05 25; 35(8):109173.
-
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates. Emerg Microbes Infect. 2020 Dec; 9(1):2076-2090.
-
A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2. Molecules. 2020 Nov 18; 25(22).
-
Identification of a Membrane Binding Peptide in the Envelope Protein of MHV Coronavirus. Viruses. 2020 09 22; 12(9).
-
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Cell. 2020 08 06; 182(3):722-733.e11.
-
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep. 2020 06 02; 31(9):107725.